https://genomadix.com/cubex_legionella_luminultra/ 2024-11-12T18:02:21+00:00 https://genomadix.com/genomadix-eyes-expanded-pgx-applications-out-licensing-for-rapid-pcr-system/ 2024-11-12T18:04:07+00:00 https://genomadix.com/stanford_adds_cyp2c19/ 2024-11-12T18:04:33+00:00 https://genomadix.com/genomadix-announces-fda-clearance-to-market-the-genomadix-cube-cyp2c19-system-2/ 2024-11-12T18:06:20+00:00 https://genomadix.com/genomadix-inc-announces-know-how-license-agreement-with-mayo-clinic-2/ 2024-11-12T18:06:28+00:00 https://genomadix.com/genomadix-inc-announces-health-canada-license-for-rapid-genetic-test-to-aid-therapy-selection-for-stroke-and-cardiovascular-disease-patients/ 2025-01-30T12:58:10+00:00 https://genomadix.com/assets-of-spartan-bioscience-inc-to-be-acquired-by-casa-dea-finance-limited/ 2025-05-13T13:10:48+00:00 https://genomadix.com/collaboration-with-mayo-clinic-on-precision-medicine-for-telestroke/ 2025-08-13T15:18:11+00:00 https://genomadix.com/genomadix-names-hollie-huff-ceo-marking-a-strategic-step-in-companys-growth-journey/ 2025-10-29T06:31:29+00:00